Eylea 2 MG/0.05 ML syringe 0.05ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMDZ9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,938
Award facts
- Contract value 100% obligated
- $29,938.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,938.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml syringes. This firm fixed-price delivery order, issued on December 8, 2025, with an ultimate completion date of December 30, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was funded by the DLA and will be performed at the contractor's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499,999,999 contract awarded on November 13, 2025, with a completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to establish multiple regional prime vendor contractors supplying a comprehensive range of pharmaceuticals, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across diverse pharmaceutical product lines positions it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FMDZ9?
SPE2DR26FMDZ9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FMDZ9 worth?
The government has obligated $29,938 on SPE2DR26FMDZ9.
Is contract SPE2DR26FMDZ9 an order under another contract?
Yes. SPE2DR26FMDZ9 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDZ9 competed?
The extent of competition for SPE2DR26FMDZ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award